NICE recommends app-based treatment for insomnia over sleeping pills
Thousands usually prescribed sleeping pills could be offered app-based treatment
Read More
Tag: insomnia
Idorsia’s Quviviq approved for adults with chronic insomnia disorder
The EC’s decision on the insomnia treatment was supported by phase 3 trial results
Read More
CHMP recommends Idorsia’s dual acting treatment Quviviq for insomnia patients
Quviviq can be used on a long-term basis, addressing a key limitation of existing therapies
Read More
Idorsia submits investigational insomnia treatment daridorexant to the EMA
Daridorexant is a dual orexin receptor agonist (DORA) designed for the treatment of insomnia
Read More
FDA pushes for stronger warnings on insomnia medicines
The change comes after reports of rare but serious injuries and deaths resulting from various complex sleep behaviours.
Read More
EU clears J&J’s Actelion buy, with conditions
The European Commission has issued a conditional green light for Johnson & Johnson’s planned $30 billion purchase of Actelion, laying out the commitments it feels are necessary to ensure that clinical development of the firms’ innovative insomnia drugs will not be adversely affected by the merger.
Read More
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
- Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination
- HUTCHMED begins phase 3 stage of pancreatic cancer trial
